Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...

Employees at a downtown Greenville-based insurance company are without a job after they said company leaders closed its ...

Trump’s decision to save TikTok shifted from his original desire to ban the app during his first term as president. TikTok ...

“We’re pleased to be back creating content on TikTok, continuing to learn more about that audience and sharing all that’s ...

We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other high ...

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other dividend ...

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...

The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the Inflation Reduction Act.

"As a healthcare company with a disease-centric approach, we are improving the standard of care in a broad range of diseases with high unmet need, including multiple myeloma, lung cancer, inflammatory ...

CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...